Phase Ib study of combinations of avadomide (CC‐122), CC‐223, CC‐292, and rituximab in patients with relapsed/refractory diffuse large B‐cell lymphoma
暂无分享，去创建一个
I. Flinn | A. Santoro | P. Hagner | J. Kuruvilla | V. Ribrag | J. Chavez | P. Cassier | J. Chandler | M. Pourdehnad | P. Corradini | K. Hege | J. Kaplan | I. Isufi | R. Sangha | C. Boccomini | S. Uttamsingh | V. Kenkre | A. Gandhi | R. Advani | F. Shen | Sophie Michelliza | Harald Haeske